Cannabis use among adults undergoing cancer treatment

Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2023-11, Vol.129 (21), p.3498-3508
Hauptverfasser: Azizoddin, Desiree R, Cohn, Amy M, Ulahannan, Susanna V, Henson, Christina E, Alexander, Adam C, Moore, Kathleen N, Holman, Laura L, Boozary, Laili Kharazi, Sifat, Munjireen S, Kendzor, Darla E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3508
container_issue 21
container_start_page 3498
container_title Cancer
container_volume 129
creator Azizoddin, Desiree R
Cohn, Amy M
Ulahannan, Susanna V
Henson, Christina E
Alexander, Adam C
Moore, Kathleen N
Holman, Laura L
Boozary, Laili Kharazi
Sifat, Munjireen S
Kendzor, Darla E
description Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not. Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days. Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety. Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology. Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.
doi_str_mv 10.1002/cncr.34922
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11070130</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2876172084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-d5e79b7d67806e666205f1b55b1c2549b71127d2a29183433b79d8aca85957ba3</originalsourceid><addsrcrecordid>eNpdkU1LAzEQhoMotlYv_gApeBFh6-RrszmJFL-g4EXBW8hm07plN6nJruC_N7W1qKdhZh7e-XgROsUwwQDkyjgTJpRJQvbQEIMUGWBG9tEQAIqMM_o6QEcxLlMqCKeHaEAF5QwkHSI-1c7pso7jPtqxbr1bjHXVN10quMqGha9TxWhnbBh3wequta47Rgdz3UR7so0j9HJ3-zx9yGZP94_Tm1lmqMBdVnErZCmqXBSQ2zzPCfA5LjkvsSGcpRbGRFREE4kLyigthawKbXTBJRelpiN0vdFd9WVrK5NGB92oVahbHT6V17X623H1m1r4D4UxCMAUksLFViH4997GTrV1NLZptLO-j4oURDIic8ISev4PXfo-uHRfokSOBYFiTV1uKBN8jMHOd9tgUGs71NoO9W1Hgs9-779Df_5PvwCAnoS8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876172084</pqid></control><display><type>article</type><title>Cannabis use among adults undergoing cancer treatment</title><source>Wiley Free Content</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Azizoddin, Desiree R ; Cohn, Amy M ; Ulahannan, Susanna V ; Henson, Christina E ; Alexander, Adam C ; Moore, Kathleen N ; Holman, Laura L ; Boozary, Laili Kharazi ; Sifat, Munjireen S ; Kendzor, Darla E</creator><creatorcontrib>Azizoddin, Desiree R ; Cohn, Amy M ; Ulahannan, Susanna V ; Henson, Christina E ; Alexander, Adam C ; Moore, Kathleen N ; Holman, Laura L ; Boozary, Laili Kharazi ; Sifat, Munjireen S ; Kendzor, Darla E</creatorcontrib><description>Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not. Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days. Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety. Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology. Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.34922</identifier><identifier>PMID: 37354093</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Adults ; Anxiety ; Appetite loss ; Cancer ; Cancer Pain - drug therapy ; Cancer Pain - epidemiology ; Cancer therapies ; Cannabis ; Female ; Government programs ; Headache ; Health risks ; Humans ; Insurance ; Male ; Males ; Marijuana ; Medicaid ; Medical marijuana ; Medical Marijuana - adverse effects ; Middle Aged ; Muscle pain ; Muscles ; Narcotics ; Nausea ; Nausea - chemically induced ; Nausea - epidemiology ; Neoplasms - drug therapy ; Neoplasms - therapy ; Oncology ; Pain ; Patients ; Sleep ; Sleep disorders ; Sleep Wake Disorders ; Spasm - drug therapy ; Spasms ; Vomiting</subject><ispartof>Cancer, 2023-11, Vol.129 (21), p.3498-3508</ispartof><rights>2023 American Cancer Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-d5e79b7d67806e666205f1b55b1c2549b71127d2a29183433b79d8aca85957ba3</citedby><cites>FETCH-LOGICAL-c371t-d5e79b7d67806e666205f1b55b1c2549b71127d2a29183433b79d8aca85957ba3</cites><orcidid>0000-0002-5803-0718 ; 0000-0002-5419-4125 ; 0000-0001-6993-1776</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37354093$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Azizoddin, Desiree R</creatorcontrib><creatorcontrib>Cohn, Amy M</creatorcontrib><creatorcontrib>Ulahannan, Susanna V</creatorcontrib><creatorcontrib>Henson, Christina E</creatorcontrib><creatorcontrib>Alexander, Adam C</creatorcontrib><creatorcontrib>Moore, Kathleen N</creatorcontrib><creatorcontrib>Holman, Laura L</creatorcontrib><creatorcontrib>Boozary, Laili Kharazi</creatorcontrib><creatorcontrib>Sifat, Munjireen S</creatorcontrib><creatorcontrib>Kendzor, Darla E</creatorcontrib><title>Cannabis use among adults undergoing cancer treatment</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not. Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days. Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety. Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology. Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.</description><subject>Adult</subject><subject>Adults</subject><subject>Anxiety</subject><subject>Appetite loss</subject><subject>Cancer</subject><subject>Cancer Pain - drug therapy</subject><subject>Cancer Pain - epidemiology</subject><subject>Cancer therapies</subject><subject>Cannabis</subject><subject>Female</subject><subject>Government programs</subject><subject>Headache</subject><subject>Health risks</subject><subject>Humans</subject><subject>Insurance</subject><subject>Male</subject><subject>Males</subject><subject>Marijuana</subject><subject>Medicaid</subject><subject>Medical marijuana</subject><subject>Medical Marijuana - adverse effects</subject><subject>Middle Aged</subject><subject>Muscle pain</subject><subject>Muscles</subject><subject>Narcotics</subject><subject>Nausea</subject><subject>Nausea - chemically induced</subject><subject>Nausea - epidemiology</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - therapy</subject><subject>Oncology</subject><subject>Pain</subject><subject>Patients</subject><subject>Sleep</subject><subject>Sleep disorders</subject><subject>Sleep Wake Disorders</subject><subject>Spasm - drug therapy</subject><subject>Spasms</subject><subject>Vomiting</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU1LAzEQhoMotlYv_gApeBFh6-RrszmJFL-g4EXBW8hm07plN6nJruC_N7W1qKdhZh7e-XgROsUwwQDkyjgTJpRJQvbQEIMUGWBG9tEQAIqMM_o6QEcxLlMqCKeHaEAF5QwkHSI-1c7pso7jPtqxbr1bjHXVN10quMqGha9TxWhnbBh3wequta47Rgdz3UR7so0j9HJ3-zx9yGZP94_Tm1lmqMBdVnErZCmqXBSQ2zzPCfA5LjkvsSGcpRbGRFREE4kLyigthawKbXTBJRelpiN0vdFd9WVrK5NGB92oVahbHT6V17X623H1m1r4D4UxCMAUksLFViH4997GTrV1NLZptLO-j4oURDIic8ISev4PXfo-uHRfokSOBYFiTV1uKBN8jMHOd9tgUGs71NoO9W1Hgs9-779Df_5PvwCAnoS8</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Azizoddin, Desiree R</creator><creator>Cohn, Amy M</creator><creator>Ulahannan, Susanna V</creator><creator>Henson, Christina E</creator><creator>Alexander, Adam C</creator><creator>Moore, Kathleen N</creator><creator>Holman, Laura L</creator><creator>Boozary, Laili Kharazi</creator><creator>Sifat, Munjireen S</creator><creator>Kendzor, Darla E</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5803-0718</orcidid><orcidid>https://orcid.org/0000-0002-5419-4125</orcidid><orcidid>https://orcid.org/0000-0001-6993-1776</orcidid></search><sort><creationdate>20231101</creationdate><title>Cannabis use among adults undergoing cancer treatment</title><author>Azizoddin, Desiree R ; Cohn, Amy M ; Ulahannan, Susanna V ; Henson, Christina E ; Alexander, Adam C ; Moore, Kathleen N ; Holman, Laura L ; Boozary, Laili Kharazi ; Sifat, Munjireen S ; Kendzor, Darla E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-d5e79b7d67806e666205f1b55b1c2549b71127d2a29183433b79d8aca85957ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Anxiety</topic><topic>Appetite loss</topic><topic>Cancer</topic><topic>Cancer Pain - drug therapy</topic><topic>Cancer Pain - epidemiology</topic><topic>Cancer therapies</topic><topic>Cannabis</topic><topic>Female</topic><topic>Government programs</topic><topic>Headache</topic><topic>Health risks</topic><topic>Humans</topic><topic>Insurance</topic><topic>Male</topic><topic>Males</topic><topic>Marijuana</topic><topic>Medicaid</topic><topic>Medical marijuana</topic><topic>Medical Marijuana - adverse effects</topic><topic>Middle Aged</topic><topic>Muscle pain</topic><topic>Muscles</topic><topic>Narcotics</topic><topic>Nausea</topic><topic>Nausea - chemically induced</topic><topic>Nausea - epidemiology</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - therapy</topic><topic>Oncology</topic><topic>Pain</topic><topic>Patients</topic><topic>Sleep</topic><topic>Sleep disorders</topic><topic>Sleep Wake Disorders</topic><topic>Spasm - drug therapy</topic><topic>Spasms</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Azizoddin, Desiree R</creatorcontrib><creatorcontrib>Cohn, Amy M</creatorcontrib><creatorcontrib>Ulahannan, Susanna V</creatorcontrib><creatorcontrib>Henson, Christina E</creatorcontrib><creatorcontrib>Alexander, Adam C</creatorcontrib><creatorcontrib>Moore, Kathleen N</creatorcontrib><creatorcontrib>Holman, Laura L</creatorcontrib><creatorcontrib>Boozary, Laili Kharazi</creatorcontrib><creatorcontrib>Sifat, Munjireen S</creatorcontrib><creatorcontrib>Kendzor, Darla E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Azizoddin, Desiree R</au><au>Cohn, Amy M</au><au>Ulahannan, Susanna V</au><au>Henson, Christina E</au><au>Alexander, Adam C</au><au>Moore, Kathleen N</au><au>Holman, Laura L</au><au>Boozary, Laili Kharazi</au><au>Sifat, Munjireen S</au><au>Kendzor, Darla E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabis use among adults undergoing cancer treatment</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>129</volume><issue>21</issue><spage>3498</spage><epage>3508</epage><pages>3498-3508</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Little is known about the risks and benefits of cannabis use in the context of cancer care. This study characterized the prevalence, reasons for use, and perceived benefits of cannabis and compared symptoms and perceived risks between those who reported past 30-day cannabis use and those who did not. Adults undergoing cancer treatment at a National Cancer Institute-designated cancer center completed measures of sociodemographic characteristics, cannabis use, use modalities, reasons for use, perceived harms/benefits of use, physical and psychological symptoms, and other substance/medication use. Analyses compared patients who used or did not use cannabis in the past 30 days. Participants (N = 267) were 58 years old on average, primarily female (70%), and predominantly White (88%). Over a quarter of respondents (26%) reported past 30-day cannabis use, and among those, 4.5% screened positive for cannabis use disorder. Participants who used cannabis most often used edibles (65%) or smoked cannabis (51%), and they were younger and more likely to be male, Black, and disabled, and to have lower income and Medicaid insurance than participants who did not use cannabis. Those who used cannabis reported more severe symptoms and perceived cannabis as less harmful than those who did not use cannabis. The most common medical reasons for cannabis use were pain, cancer, sleep problems, anxiety, nausea/vomiting, and poor appetite. Participants reported the greatest cannabis-related symptom relief from sleep problems, nausea/vomiting, headaches, pain, muscle spasms, and anxiety. Patients with cancer who used cannabis perceived benefits for many symptoms, although they showed worse overall symptomatology. Among adults undergoing cancer treatment, 26% reported cannabis use in the past 30 days. Those who used cannabis were more likely to be male and disabled and to have lower income and Medicaid insurance than those who did not use cannabis. Participants most commonly reported using cannabis for pain, cancer, sleep, anxiety, and nausea/vomiting and reported the greatest perceived benefits for sleep, nausea/vomiting, headaches, pain, muscle spasms, and anxiety, yet participants who used cannabis also reported feeling worse physically and psychologically compared to those who did not use cannabis. Participants who used cannabis were more likely to report that cannabis was less risky to their health than alcohol, smoking, and opioids than those who did not use cannabis.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37354093</pmid><doi>10.1002/cncr.34922</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-5803-0718</orcidid><orcidid>https://orcid.org/0000-0002-5419-4125</orcidid><orcidid>https://orcid.org/0000-0001-6993-1776</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2023-11, Vol.129 (21), p.3498-3508
issn 0008-543X
1097-0142
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11070130
source Wiley Free Content; MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Adults
Anxiety
Appetite loss
Cancer
Cancer Pain - drug therapy
Cancer Pain - epidemiology
Cancer therapies
Cannabis
Female
Government programs
Headache
Health risks
Humans
Insurance
Male
Males
Marijuana
Medicaid
Medical marijuana
Medical Marijuana - adverse effects
Middle Aged
Muscle pain
Muscles
Narcotics
Nausea
Nausea - chemically induced
Nausea - epidemiology
Neoplasms - drug therapy
Neoplasms - therapy
Oncology
Pain
Patients
Sleep
Sleep disorders
Sleep Wake Disorders
Spasm - drug therapy
Spasms
Vomiting
title Cannabis use among adults undergoing cancer treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A50%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabis%20use%20among%20adults%20undergoing%20cancer%20treatment&rft.jtitle=Cancer&rft.au=Azizoddin,%20Desiree%20R&rft.date=2023-11-01&rft.volume=129&rft.issue=21&rft.spage=3498&rft.epage=3508&rft.pages=3498-3508&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.34922&rft_dat=%3Cproquest_pubme%3E2876172084%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876172084&rft_id=info:pmid/37354093&rfr_iscdi=true